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Background: Predicting fluid responsiveness is crucial for fluid administration in septic
shock patients. Midazolam and propofol decrease vascular tone and venous return, which
may influence preload dependency. However, little is known about the effects of these two
sedatives on preload dependency in septic shock patients. We evaluated the effects of
sedation with propofol or midazolam on preload dependency in septic shock patients who
have been fluid resuscitated.
Methods: Forty-three septic shock patients who were undergoing early goal-directed ther-
apy resuscitated within 24 h were enrolled. The patients were randomly divided into the
midazolam group and the propofol group. An initial passive leg-raising test (PLR1) was
performed to evaluate passive leg raising test (PLR) responsiveness. Then, the patients
were infused with midazolam or propofol. After increasing the doses of the sedatives to
titrate to a Ramsay 4 score, a second passive leg raising test (PLR2) was conducted to
evaluate PLR responsiveness. The primary end-point was the preload dependency before
and after sedation with midazolam or propofol.
Results: In the midazolam-PLR1-negative patients, there was no difference between the
changes in the cardiac index induced by PLR1 (PLR1-D cardiac function index [CI]) and the
changes in the cardiac index induced by PLR2 (PLR2-D CI) (þ1.4%  7.4% versus
þ1.7%  6.4%, P > 0.05). However, in the propofol-PLR1-negative patients, there was a
significant increase in the PLR-D CI after sedation to a Ramsay 4 score compared with a
Ramsay 3 score (þ7.3%  4.8% versus þ3.2%  4.7%, P ¼ 0.008). There were no differences
between PLR1-D CI and PLR2-D CI within the midazolam-PLR1-positive patients or within
the propofol-PLR1-positive patients.
Conclusions: In titrating the sedation level from a Ramsay 3 score to a Ramsay 4 score,
propofol but not midazolam increased preload dependency in septic shock patients with
fluid nonresponsiveness.
ª 2015 The Authors. Published by Elsevier Inc. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).er: NCT 02050893
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j o u r n a l o f s u r g i c a l r e s e a r c h 1 9 3 ( 2 0 1 5 ) 8 4 9e8 5 58501. Introduction for mechanical ventilation in the absence of baseline sedativeVolume expansion is commonly used in critically ill patients
to improve their hemodynamic conditions, which is based on
their volume responsivity. In a previous report, fewer than
50% of the patients responded to the volume expansion that
was deemed necessary by the clinicians [1]. In other studies,
exacerbated pulmonary edema and septic shock concurrent
with an increased extravascular lung water index caused
significant challenges to the lifesaving procedures in preload
unresponsive patients [2,3]. Therefore, it is of prime impor-
tance to improve the preload dependency of septic shock
patients.
Infection, trauma, pain, a prolonged mechanical ventila-
tion time, and/or septic shock forces critically ill patients into
a state of severe stress, which can contribute to myocardial
ischemia, arrhythmia, gastrointestinal tract ischemia, and
stress ulcers. In addition, catecholamine (CA) levels are
markedly increased in severe stress reactions in the intensive
care unit (ICU) setting [4]. As CA is able to attenuate the pre-
load dependency of the heart in patients [5], we speculated
that a decreased preload dependency may exist in those with
a severe stress reaction.
Currently, propofol and midazolam are the most widely
used drugs for the sedation of patients in the ICU [6,7]. As
blocking agents for the sympathetic nervous system, they can
inhibit the activity of the autonomic nervous system [8,9].
Sedation can attenuate the release of CA in vivo [10,11] leading
to remarkable decreases in the stress reaction caused by
noxious stimulation as well as potential decreases in the
cardiac preload and peripheral resistance. In our previous
observational study [12], we confirmed that a propofol infu-
sion, but not a dexmedetomidine infusion, can increase the
preload dependency in circulatory failure patients. Never-
theless, the study included pooled septic and nonseptic pa-
tients. The effect of sedative drugs on preload dependency in
septic shock patients remains unclear. The vascular tone and
the ability to respond to drugs in septic shock are different
compared with nonseptic shock conditions because of vaso-
paresis. Forty-three patients with the clinical manifestations
of septic shock were included in this study. A passive leg
raising test (PLR) test was performed to evaluate the patients’
cardiac preload dependency before and after increasing the
sedation level (using propofol or midazolam) from a Ramsay
score 3 to a Ramsay score 4.2. Methods
2.1. Patients
Forty-three septic shock patients admitted to the ICU from
May 2012eMay 2013 were included in this prospective, non-
blinded, randomized, controlled study. The study was regis-
tered as project number NCT02050893 with clinicaltrials.gov
and was approved by the Ethics Committee of the Zhongda
Hospital of Southeast University (2012ZDllKY24.0). Informed
consent was obtained. The inclusion criteria were as follows:
the need for sedative therapy due to anxiety and/or the needagent administration. The criteria of septic shockwere based on
American College Of Chest Physicians/Society Of Critical Care
Medicine (ACCP/SCCM) Consensus 2012. The patients met
early goal-directed therapy (EGDT) criteria including [13]: [1] a
central venous pressure (CVP) of 8e12 mm Hg; [2] a mean
arterial pressure of65 mmHg; [3] urine output of >0.5 mL/kg
per hour; and [4] a central venous blood oxygen saturation
(ScvO2) of 70% or higher or a mixed venous oxygen saturation
(SvO2) of 65% or higher. The exclusion criteria were as follows:
(1) aged <18 y; (2) an intra-abdominal pressure of >12 mmHg;
(3) a central nervous system pathology; (4) a second-degree
heart blockage or third-degree heart blockage, bradycardia,
heart blockage, acute coronary syndrome, cardiac shock, or
use of intra-aortic balloon pump; (5) contraindications to PLR,
such as a craniocerebral injury and venous thrombosis; (6)
severe liver disease (ChildePugh class C); or (7) a systolic blood
pressure of <90 mm Hg despite vasopressor infusion.
2.2. Measurements
Anopiate drugwas administered to induce analgesia before the
study. No modulation was performed in the doses of the
vasoactive agent and analgesics, respirator parameters, and
fluid infusion rate. The patients were monitored by CVP mea-
surements, using an invasive arterial pressure and a PiCCO2
(Pulsion Medical Systems, Munich, Germany) device. Previous
studies have confirmed the utility of PiCCO measurements for
assessing the preload dependency in septic shock patients
[5,14]. The cardiac output (CO) and stroke volume were deter-
mined with a PiCCO2 device and measured by transpulmonary
thermodilution before and after the study drug (propofol or
midazolam) infusion and by a pulse contour analysis before
and after the PLR tests. Themaximal pressure developed by the
left ventricle (dP/dtmax) and global end-diastolic volume (GEDI)
index were determined with the PiCCO2 device.
2.3. Study design
An initial PLR test (PLR1) was performed in all the patients to
evaluate the preload dependency at baseline. PLR was per-
formed by transferring the patients from a semirecumbent
position to a horizontal position with the legs elevated at 45
[12]. Propofol and midazolam were infused and titrated ac-
cording to the Ramsay scale; the goal of the sedation was to
increase the sedation level from Ramsay score 3 to Ramsay
score 4. Preload dependency was assessed by a PLR test ac-
cording to the previously documented methods [5]. A patient
was considered to have a positive PLR test finding if the
change in the cardiac function index (CI) induced by the PLR
increased by10% during the PLR test [5]. An initial bolus dose
of 0.05 mg/kg of midazolam, followed by a continuous infu-
sion with 0.05e0.1 mg/kg/h or an initial bolus dose of 0.5 mg/
kg propofol, and then continuous infusion with 0.5e2.0 mg/
kg/h was administered. The infusion rate of the propofol or
midazolamwas titrated to maintain the target sedation depth
of Ramsay score 4. After 40min, when a suitable sedation level
was achieved and the hemodynamic variables were stabi-
lized, a second PLR test (PLR2) was then performed. Treatment
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tolic blood pressure of <80 mmHg or a 30% decrease from the
baseline [7] was observed, a bolus of intravenous fluid was
administered, the sedative drug infusion was interrupted, and
vasoactive agents were administered if needed.
2.4. Statistical analysis
The data are expressed as themean standard deviation or as
the median (25%e75% interquartile range), as appropriate.
The statistical analysis was performed by a two-way repeated
measurements analysis of variance. A Bonferroni correction
was applied in the case of multiple post hoc pairwise com-
parisons. The data were compared between the different
propofol and midazolam groups of patients using a two-
sample Student t-test, ManneWhitney U test, or Fisher exact
test, as appropriate. The power of the study was a posteriori
calculated to be 80% for evidencing a 10% decrease in CO of
Ramsay score 3. A P value < 0.05 was considered significant.
We conducted the statistical analyses using the SPSS 16.0
software package (SPSS Inc, Chicago, IL).3. Results
3.1. Patient characteristics
Seven hundred twenty-four patients were screened, of whom
125 patients were diagnosed with septic shock. Of these, 82
patients were excluded because of severe cardiac dysfunctionTable 1 e Patient characteristic at baseline.
Data Midazola
Age (y) 77 (6
Gender (number of patients, male/female) 1
Height (cm) 1.67
Weight (kg) 65
APACHE II 16
Sequential organ failure assessment score 9
28 d mortality (%) 3
Source of infection (number of patients)
Pneumonia 19
Peritoneal cavity 2
Hematogenous 0
Vasoactive drugs, n (%)
Norepinephrine 18
Dobutamine 2
Dopamine 3 (
Hemodynamics value
CVP (mm Hg) 10
MAP (mm Hg) 84
ScvO2 (%) 81.7
Mechanical ventilation, n (%)
Tidal volume (mL kg1 predicted body weight) 8 (
Positive end-expiratory pressure (cm H2O) 8 (5
Lactate (mmol/L) 2.3 (1
Time from EGDT achieved to inclusion (h) 20 (
Total fluid administration before inclusion (mL) 4054 (30
APACHE II ¼ Acute Physiology and Chronic Health Evaluation II; MAP ¼ m
Values are expressed as the means (standard deviation) or the median (r(27%), unconsciousness with central nervous system pathol-
ogy (13%), contraindications for PLR or unstable hemo-
dynamics (e.g., an SBP of <90 mm Hg despite vasopressor
infusion (25%)), or who met other exclusion criteria, such as
the PiCCO or central venous catheters being unavailable (12%)
or an inability to achieve EGDT before the sedative drugs were
used (25%). Forty-three septic shock patients were enrolled in
this study. The patients were divided into two groups as fol-
lows: the midazolam group (n ¼ 21) and the propofol group
(n ¼ 22). The patient characteristics are summarized in
Table 1. There were no statistically significant differences in
the clinical characteristics, background medical therapy, or
28-d mortality between these groups. In addition, there were
no statistically significant differences in the time before in-
clusion from the EGDT achieved or in the total fluid balance
before inclusion. In the midazolam group, the patients were
divided into two groups at baseline according to preload de-
pendency as follows: a positive PLR1 group (n ¼ 9) and a
negative PLR1 group (n ¼ 12). In the propofol group, the pa-
tients were divided into two groups at baseline according to
their preload dependency as follows: a positive PLR1 group
(n ¼ 8) and a negative PLR1 group (n ¼ 14).3.2. Changes in hemodynamic variables on sedation
with propofol or midazolam
Propofol was administered as a bolus dose of 30 (interquartile
range: 30e35 mg) and was continuously infused at 50
mg h1(interquartile range: 33e60). Midazolam was adminis-
tered as a bolus dose of 2.5 (interquartile range: 2.0e3.0 mg)m (n ¼ 21) Propofol (n ¼ 22) P value
3e82) 72 (60e76) 0.302
2/9 14/8 0.760
 0.06 1.67  0.07 0.773
 8 64  12 0.848
 6 15  6 0.393
 3 9  3 0.490
3.3 31.8 1.000
(90.5) 15 (68.2) 0.132
(9.5) 6 (27.3) 0.240
(0) 1 (4.5) 1.000
(85.7) 20 (90.9) 0.664
(9.5) 1 (4.5) 1.000
14.3) 1 (4.5) 0.607
 3 10  2 1.000
 13 89  13 0.247
 4.7 82.9  3.2 0.593
8e9) 8 (8e9) 0.958
e10) 7 (5e10) 0.386
.2e2.5) 2.1 (1.2e3.2) 0.864
6e24) 17 (5e24) 0.525
00e7267) 4001 (2604e4690) 0.466
ean arterial pressure.
ange).
Table 2 e Hemodynamic variables during the propofol
and midazolam study drug infusion.
Hemodynamic
variable
Ramsay score 3 Ramsay score 4
HR (beats/min)
Midazolam (n ¼ 21) 94  17 89  18*
Propofol (n ¼ 22) 90  12 87  14*
CVP (mm Hg)
Midazolam (n ¼ 21) 10  3 9  4
Propofol (n ¼ 22) 10  3 9  3
MAP (mm Hg)
Midazolam (n ¼ 21) 84  11 81  13
Propofol (n ¼ 22) 88  14 87  14
CI (L/min/m2)
Midazolam (n ¼ 21) 3.7  0.9 3.4  0.9*
Propofol (n ¼ 22) 4.0  0.9 3.7  0.9*
SVI (mL/m2)
Midazolam (n ¼ 21) 41  13 40  13
Propofol (n ¼ 22) 45  13 44  12
SVRI (dynes s/cm5/m2)
Midazolam (n ¼ 21) 1690  356 1769  482
Propofol (n ¼ 22) 1677  540 1763  588
dP/dtmax (mm Hg/s)
Midazolam (n ¼ 21) 1535  519 1417  570
Propofol (n ¼ 22) 1275  461 1224  430
GEDI (mL/m2)
Midazolam (n ¼ 21) 820  148 763  140
Propofol (n ¼ 22) 803  137 784  153
HR¼ heart rate; MAP¼mean arterial pressure; SVI¼ stroke volume
index; SVRI ¼ systemic vascular resistance index.
The data are presented as the mean values (standard deviation).
*P < 0.01 Ramsay score 3 versus Ramsay score 4.
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1.2e2.0). No significant difference was observed in the dose of
propofol or midazolam in the subgroups of patients with
negative or positive PLR1 tests. There were significant de-
creases in the heart rate and CI after propofol or midazolam
sedation (both P < 0.01). There were no differences between
the two groups. No significant decreases in the CVP, mean
arterial pressure, stroke volume index, systemic vascular
resistance index, dp/max, and GEDI were observed after the
propofol or midazolam sedation (Table 2).3.3. The effects of sedation with propofol or midazolam
on preload dependency
There were no significant differences in the PLR-D CI in the
midazolam group compared within the propofol group at
baseline. The analysis was carried out according to whether
the PLR1 was positive. In the midazolam-PLR1-negative pa-
tients, there was no difference between the PLR1-D CI and the
PLR2-D CI (þ1.4%  7.4% versus þ1.7%  6.4%, P > 0.05).
Additionally, in the midazolam-PLR1-positive patients, there
was no difference between the PLR1-D CI and the PLR2-D CI
(þ19.9% 8.4% versusþ18.6% 12.6%, P> 0.05). By contrast, in
the propofol-PLR1-negative patients, there was a significant
increase in the PLR-D CI after sedation to Ramsay 4 score
compared with Ramsay 3 score (þ7.3%  4.8% versus
þ3.2%  4.7%, P ¼ 0.008). There was no significant difference
between the PLR1-D CI and the PLR2-D CI (þ22.0%  6.5%versus þ16.5%  6.5%, P > 0.05) in the propofol-PLR1-positive
patients (Figure).4. Discussion
In this study, we investigated the effects on preload de-
pendency of propofol andmidazolam in septic shock patients.
Our results indicated the following: (1) a remarkable decrease
in CO was induced after propofol or midazolam infusion in
these patients and (2) remarkable changes in CI were noted
after propofol but not midazolam infusion during the PLR2
compared with those obtained after the PLR1 in the subgroups
patients with a negative PLR1 test, which demonstrated that
the preload dependency among the patients with propofol
infusion (sedation change to Ramsey score 4) was enhanced.4.1. The effects of propofol on the cardiac preload
dependency
The influence of propofol on the systemic circulation in crit-
ically ill patients has not been well defined. As a short-acting,
intravenously administered hypnotic agent that can inhibit
the function of the central nervous system through the
potentiation of gamma-amino-butyric acid receptor activity,
propofol has been commonly used for the induction and
maintenance of general anesthesia since 1980. However,
propofol can attenuate the release of CA in vivo, resulting in a
decrease in the cardiac preload [9]. In our study, after propofol
infusion, a significant difference was noted in the hemody-
namics. No significant difference was noted in the cardiac
contractility. Nevertheless, a significant decrease in the arte-
rial blood pressure was observed because of angiotasis and
decreased venous return [15e19]. In our study, no significant
decrease was observed in CVP after propofol infusion. In
addition, a remarkable preload dependency increase was
noted after the sedation level increase from Ramsay score 3 to
Ramsay score 4 among the PLR-negative patients in the pro-
pofol subgroups. According to a previous report, propofol
causes a direct relaxation of both the venous and arterial tis-
sue, with the venous effects occurring at a lower propofol
concentration. Moreover, further evidence has indicated that
clinically relevant concentrations of propofol do not induce
direct artery vasodilator effects [20].
Although we cannot determine the stressed and un-
stressed volumes directly, our results have demonstrated a
partial transfer from the stressed to the unstressed volume,
that is, a large reserve of unstressed volume was formed to
maintain the vascular filling pressure [21]. In addition, the
relaxation of the venous blood vessels in the patients with a
preload dependency was significantly different from those
without. These results indicated that obvious vasodilatation
was induced in the patients with a preload dependency after
propofol infusion. This effect should be given close attention
during the resuscitation of septic shock patients. We specu-
late that this effect might be associated with the venous blood
flow recruited during the PLR2 caused by the propofol-induced
vasodilatation, which is in contrast with the vasoconstrictive
effects caused by noradrenaline. Moreover, an alteration of
Figure e The effects of sedation on the preload dependency. The PLR-D CI, relative percentage changes in CI induced by a
PLR (compared with before PLR1), and a PLR performed during the sedation (compared with before the PLR2); the P value
indicates a significant difference between the Ramsay score 4 versus Ramsay score 3, in the midazolam negative PLR1 group
(A) (n [ 12), in the propofol negative PLR1 group (B) (n [ 14), in the midazolam positive PLR1 group (C) (n [ 9), and in the
propofol positive PLR1 group (D) (n [ 8).
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propofol.
4.2. The effects of midazolam on cardiac preload
dependency
Midazolam had less of an effect on the cardiac preload
although it had certain vasodilation effects. Midazolam is a
water-soluble benzodiazepinewith a rapid onset of action and
a short elimination half-life; in addition, midazolam does not
have active metabolites and an adrenal steroidogenesis
inhibitory effect [22]. Thus, it may be a good sedative drug of
choice to decrease mortality in adults with refractory status
epilepticus [23]. Currently, it is widely used in the ICU because
of its own favorable properties [6,7]. In our unit, midazolam is
usually used as a continuous intravenous infusion followed by
a bolus dose for short-term sedation. Used in this way, an
adequate sedation level (Ramsay score 4) is quickly achieved
that is neither too deep nor inadequate.
In the present study, midazolam did not increase preload
dependency as assessed by the PLR2-D CI in septic shock pa-
tients with an increased sedation level fromRamsay score 3 to
Ramsay score 4. This result most likely occurred because
midazolam did not alter the cardiac preload significantly, as
indicated by the CVP and GEDI surrogates in these patients.
Another possible reason is that the patients included into the
study were patients with septic shock, whose blood vesselswere already paralyzed; thus, the weak vasodilation effect of
midazolamwould have been unable to dilate the blood vessels
significantly or lead to a significant cardiac preload decrease.
Furthermore, midazolam infusion did not change the cardiac
function, as indicated by dP/dtmax; as a result, preload de-
pendency did not increase markedly, although the venous
return (as shown by the CO) decreased somewhat from
baseline. These hemodynamic effects are different from an
animal study that used a large dose [24] from healthy patients
undergoing anaesthesia [25].
4.3. Clinical implications
Our study indicates that sedation can also impact preload
dependency. Our study was conducted in a postseptic shock
clinical setting consistent with the way that patients are often
received, which includes fluid resuscitation and/or CA; thus,
the similar effect that propofol or midazolam induced could
be expected in clinical use.
In the present study, only a slight decrease in CO in the
patients after propofol or midazolam infusion was observed.
This result is particularly important to emphasize in patients
with septic shock because no further decrease in tissue oxy-
gen delivery occurs after infusion. A previous study has
shown that propofol or midazolam infusion for sedation
preserved the hemodynamics in critically ill patients after
coronary artery bypass grafting [26]. Therefore, one might
j o u r n a l o f s u r g i c a l r e s e a r c h 1 9 3 ( 2 0 1 5 ) 8 4 9e8 5 5854expect that propofol or midazolam could be used safely in
patients’ septic shock, which may already present with car-
diac injury because such treatment may result in good he-
modynamic tolerance.
Volume expansion is critical for the appropriate treatment
of patients with hemodynamic compromise. In addition, non-
discriminate fluid administration has the potential to induce
or exacerbate pulmonary edema and fluid overload, particu-
larly in patients with sepsis [2,3]. An adequate preload de-
pendency is critical for critically ill patients with clinical
evidence of insufficient organ perfusion pressure. The preload
dependency of intensive care patients can be altered by the
general state of stress and high CA levels [5].
Most importantly, we found that preload dependency
increased after a suitable sedationwith propofol infusion; this
treatment may benefit patients with septic shock with a
nonpreload dependency because fluid administration guided
by fluid responsiveness in critically ill patients is a matter of
fundamental importance for survival in cases involving septic
shock. This effect should be of particular importance during
the resuscitation of patients with circulatory failure.
4.4. Limitations
The limitations of our study were as follows: (1) we cannot
conclude that midazolam cannot enhance the preload de-
pendency as we only investigated the sedation level starting
from Ramsay score 3 to Ramsay score 4 in this study. Because
Ramsay score 4 is commonly used in the clinical setting, if the
sedation score were to have increased to 5 or more, the results
may have differed. (2) All the patients included in this study
received propofol, an opiate or an analog administered before
being included in the study to achieve the targeted baseline
level of sedation in the pooled studies and to facilitate the PLR
test and the PiCCO measurements. The patients in the two
groups crossed over between propofol and midazolam treat-
ment groups, reducing the power of the study drug to
demonstrate any potential benefits of the increased cardiac
preload dependency. Thus, our results may not be generaliz-
able. (3) Only short-term hemodynamics were determined in
this study. Although no significant differencewas noted in the
mortality among the patients with propofol or midazolam
sedation, we cannot determine the effects of the preload de-
pendency enhancement by propofol on the mortality and
patient outcome.5. Conclusions
In septic patients with a negative PLR test at baseline and with
an increased sedation depth from Ramsay score 3 to Ramsay
score 4, propofol but notmidazolam increased cardiac preload
dependency, as assessed by a PLR test.
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